Synovial sarcoma should be considered in the differential diagnosis of masses in the oral and maxillofacial region, and can be managed with surgical resection, radiotherapy, and chemotherapy.
Answers are grounded in this paper and cite their sources.
Supports inclusion of synovial sarcoma in oral mass differentials; leaves open optimal multimodal management strategies.
Synovial sarcoma (SS) is a malignant soft tissue tumor comprising 5-10% of all soft tissue sarcomas. This tumor normally occurs in the paraarticular regions of the extremities but is rare in head and neck sites. SS is sometimes difficult to diagnose because it can mimic benign lesions both clinically and radiologically. This paper presents a rare case of a SS of the buccal space of a 25-year old man. The histology examination and immunohistochemistry of the mass led to a diagnosis of synovial sarcoma. The patient was treated primarily with a surgical resection, followed by radiotherapy and chemotherapy. The follow up examination 17-months after surgery showed no signs of tumor relapse or metastasis.
No takes yet. Share an insight, caveat, or question.
Han et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: